SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-053304
Filing Date
2021-11-02
Accepted
2021-11-02 07:22:06
Documents
65
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q sage-10q_20210930.htm   iXBRL 10-Q 3256649
2 EX-10.1 sage-ex101_173.htm EX-10.1 26365
3 EX-10.2 sage-ex102_170.htm EX-10.2 50755
4 EX-10.3 sage-ex103_171.htm EX-10.3 35157
5 EX-10.4 sage-ex104_172.htm EX-10.4 25895
6 EX-31.1 sage-ex311_6.htm EX-31.1 9337
7 EX-31.2 sage-ex312_7.htm EX-31.2 9288
8 EX-32.1 sage-ex321_8.htm EX-32.1 8649
9 GRAPHIC gnouafmqynd3000001.jpg GRAPHIC 200811
10 GRAPHIC gedmddy3wwi5000001.jpg GRAPHIC 182195
  Complete submission text file 0001564590-21-053304.txt   10869978

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA sage-20210930.xsd EX-101.SCH 53869
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sage-20210930_cal.xml EX-101.CAL 43642
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sage-20210930_def.xml EX-101.DEF 204084
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE sage-20210930_lab.xml EX-101.LAB 410875
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sage-20210930_pre.xml EX-101.PRE 328363
16 EXTRACTED XBRL INSTANCE DOCUMENT sage-10q_20210930_htm.xml XML 1966608
Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Filer) CIK: 0001597553 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36544 | Film No.: 211369258
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences